Life sciences company Azenta (NASDAQ:AZTA) fell short of the market’s revenue expectations in Q2 CY2025, with sales flat year ...

Shares of life sciences company Azenta (NASDAQ:AZTA) fell 16.3% in the afternoon session after the company announced mixed ...

Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 3.3% in the afternoon session after an upgrade from investment ...

Gain insights from Azenta's Q3 2025 earnings call. Explore their financial strength, growth strategies, and commitment to 3%-5% revenue growth.

Azenta, Inc. ( NASDAQ: AZTA) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ET John P. Marotta - President, CEO & Director Lawrence Y. Lin - Executive VP & CFO Yvonne Perron - Vice President ...

Fintel reports that on August 6, 2025, Raymond James upgraded their outlook for Azenta (NasdaqGS:AZTA) from Market Perform to ...

Life sciences company Azenta (NASDAQ:AZTA) will be reporting results this Tuesday before the bell. Here’s what to look for.

Q3 2025 Earnings Call Transcript August 5, 2025 Azenta, Inc. misses on earnings expectations. Reported EPS is $-1.15519 EPS, expectations were $0.13. Operator: Greetings, and welcome to the Azenta Q3 ...

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable ...

Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...

FreezerPro is a web-based system that simplifies sample tracking, boosts compliance and improves lab efficiency.

Evercore ISI analyst Vijay Kumar maintained a Buy rating on Enovis today and set a price target of $44.00. The company’s shares opened today at $27.58. Elevate Your Investing St ...